Redox regulation in cancer: A double-edged sword with therapeutic potential

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 1, 2010, Pages 23-34

  Acharya, Asha ^a,c   Das, Ila ^b   Chandhok, Des ^a   Saha, Tapas ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^c GeneTarn Corporation   (United States)

Author keywords

Antioxidants; BRCA1; Cancer stem cells; Detoxification enzymes; NF B; NRF2; Phase II; ROS

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; BRCA1 PROTEIN; CAPSAICIN; CARDAMOM EXTRACT; CINNAMON EXTRACT; CISPLATIN; CLOVE EXTRACT; CURCUMIN; CYTOTOXIC AGENT; DAIDZEIN; ESTROGEN RECEPTOR; GARLIC EXTRACT; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; TRASTUZUMAB; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RISK; CANCER STEM CELL; CARCINOGENESIS; CARDAMOM; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CINNAMON; CLINICAL TRIAL; CLOVE; COLON CANCER; DRUG SENSITIVITY; EPIDEMIOLOGICAL DATA; FRUIT; GENE EXPRESSION; HEALTH CARE COST; HERB; HUMAN; NEOPLASM; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN PAPILLOMA; SPICE; VEGETABLE;

EID: 77953384917     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.1.10095     Document Type: Article

References (148)

1. Burhans WC, Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res 2007; 35:7545-56.
2. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett 2009; 282:125-36.
3. Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009; 3:73-80.
4. Addabbo F, Montagnani M, Goligorsky MS. Mitochondria and reactive oxygen species. Hypertension 2009; 53:885-92.
5. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK. Mitochondrial metabolism, redox signaling and fusion: a mitochondria- ROS-HIF-1alpha-KV1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008; 294:570-8.
6. Pool-Zobel B, Veeriah S, Bohmer FD. Modulation of xenobiotic metabolising enzymes by anticarcinogens- focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 2005; 591:74-92.
7. Barve A, Khor TO, Nair S, Reuhl K, Suh N, Reddy B, et al. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer 2009; 124:1693-9.
8. Kumaraguruparan R, Seshagiri PB, Hara Y, Nagini S. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: modulation of xenobioticmetabolizing enzymes, oxidative stress, cell proliferation, apoptosis and angiogenesis. Mol Carcinog 2007; 46:797-806.
9. Lee SB, Kim CY, Lee HJ, Yun JH, Nho CW. Induction of the Phase II Detoxification Enzyme NQO1 in Hepatocarcinoma Cells by Lignans from the Fruit of Schisandra chinensis through Nuclear Accumulation of Nrf2. Planta Med 2009; 18:18.
10. Nair S, Li W, Kong AN. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta Pharmacol Sin 2007; 28:459-72.
11. Naithani R. Organoselenium compounds in cancer chemoprevention. Mini Rev Med Chem 2008; 8:657-68.
12. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009; 47:372-81.
13. Okamura DM, Himmelfarb J. Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatr Nephrol 2009; 7:7.
14. Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 2009; 16:763-74.
15. Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJ, Perstin J, et al. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits and cancer. Toxicol Sci 2009; 108:4-18.
16. Wu D, Cederbaum AI. Oxidative stress and alcoholic liver disease. Semin Liver Dis 2009; 29:141-54.
17. Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress and Alzheimer disease. Free Radic Biol Med 2009; 46:1241-9.
18. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160:1-40.
19. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage and repair. Langenbecks Arch Surg 2006; 391:499-510.
20. Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair 2004; 3:1109-15.
21. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage and heart failure. Antioxid Redox Signal 2006; 8:1737-44. (Pubitemid 44726346)
22. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation and disease. Faseb J 2003; 17:1195-214. (Pubitemid 36775767)
23. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21:361-70.
24. Bailey DT, DeFedericis HC, Greene KF, Iijima H, Budzinski EE, Patrzyc HB, et al. A novel approach to DNA damage assessments: measurement of the thymine glycol lesion. Radiat Res 2006; 165:438-44.
25. Mambo E, Nyaga SG, Bohr VA, Evans MK. Defective repair of 8-hydroxyguanine in mitochondria of MCF-7 and MDA-MB-468 human breast cancer cell lines. Cancer Res 2002; 62:1349-55.
26. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2'-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009; 27:120-39.
27. Sheweita SA, Tilmisany AK. Cancer and phase II drug-metabolizing enzymes. Curr Drug Metab 2003; 4:45-58.
28. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004; 279:34643-54.8.
29. Vizan P, Alcarraz-Vizan G, Diaz-Moralli S, Solovjeva ON, Frederiks WM, Cascante M. Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29. Int J Cancer 2009; 124:2789-96.
30. Inokuma T, Haraguchi M, Fujita F, Tajima Y, Kanematsu T. Oxidative stress and tumor progression in colorectal cancer. Hepatogastroenterology 2009; 56:343-7.
31. Huang F, Nie C, Yang Y, Yue W, Ren Y, Shang Y, et al. Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells. Free Radic Biol Med 2009; 46:1186-96.
32. Rosen EM, Fan S, Isaacs C. BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr Relat Cancer 2005; 12:533-48.
33. Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003; 196:19-41.
34. Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, et al. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 2004; 64:7893-909.
35. Cao L, Xu X, Cao LL, Wang RH, Coumoul X, Kim SS, et al. Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach. Carcinogenesis 2007; 28:1401-7.
36. Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, et al. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 2001; 28:266-71.
37. Saha T, Rih JK, Rosen EM. BRCA1 downregulates cellular levels of reactive oxygen species. FEBS Lett 2009; 583:1535-43.
38. Kang HJ, Kim HJ, Kim SK, Barouki R, Cho CH, Khanna KK, et al. BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells. J Biol Chem 2006; 281:14654-62.
39. Jeon BH, Irani K. APE1/Ref-1: Versatility in Progress. Antioxid Redox Signal 2008; 20:20.
40. Seo Y, Kinsella TJ. Essential Role of DNA Base Excision Repair on Survival in an Acidic Tumor Microenvironment. Cancer Res 2009; 1:1.
41. Shao C, Folkard M, Held KD, Prise KM. Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation. BMC Cancer 2008; 8:184.
42. Nagai MA, Ros N, Bessa SA, Mourao Neto M, Miracca EC, Brentani MM. Differentially expressed genes and estrogen receptor status in breast cancer. Int J Oncol 2003; 23:1425-30.
43. Wang Z, Wijewickrama GT, Peng KW, Dietz BM, Yuan L, van Breemen RB, et al. Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus. J Biol Chem 2009; 284:8633-42.
44. Weitsman GE, Weebadda W, Ung K, Murphy LC. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha. Breast Cancer Res Treat 2008; 21:21.
45. Fernandez SV, Russo IH, Russo J. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer 2006; 118:1862-8.
46. Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID, et al. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 2000; 60:5635-9.
47. Razandi M, Pedram A, Rosen EM, Levin ER. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 2004; 24:5900-13.
48. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, et al. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 2006; 1766:63-78.
49. Mitra PS, Basu NK, Owens IS. Src supports UDP-glucuronosyltransferase- 2B7 detoxification of catechol estrogens associated with breast cancer. Biochem Biophys Res Commun 2009; 382:651-6.
50. Dabrosin C, Hammar M, Ollinger K. Impact of oestradiol and progesterone on antioxidant activity in normal human breast epithelial cells in culture. Free Radic Res 1998; 28:241-9.
51. Mobley JA, Brueggemeier RW. Estrogen receptormediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis 2004; 25:3-9.
52. Rao A, Ziegler Y, McLeod I, Yates J, Nardulli A. Thioredoxin and thioredoxin reductase influence estrogen receptor {alpha} mediated gene expression in human breast cancer cells. J Mol Endocrinol 2009; 20:20.
53. Benz CC, Atsriku C, Yau C, Britton D, Schilling B, Gibson BW, et al. Novel pathways associated with quinone-induced stress in breast cancer cells. Drug Metab Rev 2006; 38:601-13.
54. Yau C, Benz CC. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Res 2008; 10:17.
55. Katiyar P, Ma Y, Fan S, Pestell RG, Furth PA, Rosen EM. Regulation of progesterone receptor signaling by BRCA1 in mammary cancer. Nucl Recept Signal 2006; 4:28.
56. Katiyar P, Ma Y, Riegel A, Fan S, Rosen EM. Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. Mol Endocrinol 2009; 23:1135-46.
57. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009; 458:780-3.
58. Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007; 110:3056-63.
59. Naka K, Muraguchi T, Hoshii T, Hirao A. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal 2008; 10:1883-94.
60. Ogasawara MA, Zhang H. Redox Regulation and its Emerging Roles in Stem Cells and Stem-Like Cancer Cells. Antioxid Redox Signal 2008; 11:11.
61. Blum R, Gupta R, Burger PE, Ontiveros CS, Salm SN, Xiong X, et al. Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer. PLoS One 2009; 4:5722.
62. Boman BM, Huang E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008; 26:2828-38.
63. Hill R, Wu H. PTEN, stem cells and cancer stem cells. J Biol Chem 2009; 284:11755-9.
64. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008; 3:2888.
65. Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC, et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGFbeta and IL-6 signaling. Proc Natl Acad Sci USA 2008; 105:2445-50.
66. Tothova Z, Gilliland DG. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell 2007; 1:140-52.
67. Ito K, Bernardi R, Pandolfi PP. A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancerinitiating cell. Curr Opin Genet Dev 2009; 19:51-9.
68. Tothova Z, Gilliland DG. A radical bailout strategy for cancer stem cells. Cell Stem Cell 2009; 4:196-7.
69. Arner ES, Holmgren A. The thioredoxin system in cancer. Semin Cancer Biol 2006; 16:420-6.
70. Noike T, Miwa S, Soeda J, Kobayashi A, Miyagawa S. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Hum Pathol 2008; 39:201-8.
71. Michelet L, Zaffagnini M, Massot V, Keryer E, Vanacker H, Miginiac-Maslow M, et al. Thioredoxins, glutaredoxins and glutathionylation: new crosstalks to explore. Photosynth Res 2006; 89:225-45.
72. Tsai CM, Levitzki A, Wu LH, Chang KT, Cheng CC, Gazit A, et al. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. Cancer Res 1996; 56:1068-74.
73. Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 1998; 95:5724-9.
74. Pegram MD, Lopez A, Konecny G, Slamon DJ. Trastuzumab and chemotherapeutics: drug interactions and synergies. Semin Oncol 2000; 27:21-5.
75. Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM. Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Res 2009; 69:6083-91.
76. Fan S, Meng Q, Auborn K, Carter T, Rosen EM. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 2006; 94:407-26.
77. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269:226-42.
78. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65:1631-52.
79. Basu NK, Kole L, Basu M, Chakraborty K, Mitra PS, Owens IS. The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C. J Biol Chem 2008; 283:23048-61.
80. Basu NK, Kovarova M, Garza A, Kubota S, Saha T, Mitra PS, et al. Phosphorylation of a UDPglucuronosyltransferase regulates substrate specificity. Proc Natl Acad Sci USA 2005; 102:6285-90.
81. Basu NK, Kole L, Basu M, McDonagh AF, Owens IS. Targeted inhibition of glucuronidation markedly improves drug efficacy in mice-a model. Biochem Biophys Res Commun 2007; 360:7-13.
82. Bhattacharjee S, Rana T, Sengupta A. Inhibition of lipid peroxidation and enhancement of GST activity by cardamom and cinnamon during chemically induced colon carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev 2007; 8:578-82.
83. Das I, Chakrabarty RN, Das S. Saffron can prevent chemically induced skin carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev 2004; 5:70-6.
84. Das I, Das S, Saha T. Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: A histopathological study. Acta Histochem 2009; 26:26.
85. Das I, Saha T. Effect of garlic on lipid peroxidation and antioxidation enzymes in DMBA-induced skin carcinoma. Nutrition 2009; 25:459-71.
86. Kaefer CM, Milner JA. The role of herbs and spices in cancer prevention. J Nutr Biochem 2008; 19:347-61.
87. Salim EI, Fukushima S. Chemopreventive potential of volatile oil from black cumin (Nigella sativa L.) seeds against rat colon carcinogenesis. Nutr Cancer 2003; 45:195-202.
88. Giles GI. The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des 2006; 12:4427-43.
89. Tew KD. Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem Pharmacol 2007; 73:1257-69.
90. Copple IM, Goldring CE, Kitteringham NR, Park BK. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 2008; 246:24-33.
91. Itoh K. Protective mechanism against oxidative stress by Keap1/Nrf2 pathway. Seikagaku 2006; 78:79-92.
92. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006; 38:769-89.
93. Lee JM, Johnson JA. An important role of Nrf2- ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 2004; 37:139-43.
94. Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul 2006; 46:113-40.
95. Ding Y, Choi KJ, Kim JH, Han X, Piao Y, Jeong JH, et al. Endogenous hydrogen peroxide regulates glutathione redox via nuclear factor erythroid 2-related factor 2 downstream of phosphatidylinositol 3-kinase during muscle differentiation. Am J Pathol 2008; 172:1529-41.
96. Hsieh CY, Hsiao HY, Wu WY, Liu CA, Tsai YC, Chao YJ, et al. Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells. J Biomed Sci 2009; 16:12.
97. Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008; 74:1526-39.
98. Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 2009; 46:443-53.
99. Jin W, Wang H, Yan W, Xu L, Wang X, Zhao X, et al. Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008; 725174:25.
100. Kim SK, Yang JW, Kim MR, Roh SH, Kim HG, Lee KY, et al. Increased expression of Nrf2/AREdependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Radic Biol Med 2008; 45:537-46.
101. Czeczuga-Semeniuk E, Jarzabek K, Lemancewicz D, Wolczynski S. The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel. Gynecol Endocrinol 2009; 26:1-7.
102. Tan KP, Kosuge K, Yang M, Ito S. NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity. Free Radic Biol Med 2008; 45:1663-73.
103. Frohlich DA, McCabe MT, Arnold RS, Day ML. The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene 2008; 27:4353-62.
104. Antunes F, Han D. Redox Regulation of NFkappaB: from basic to clinical research. Antioxid Redox Signal 2009; 13:13.
105. Hagemann T, Biswas SK, Lawrence T, Sica A, Lewis CE. Regulation of macrophage function in tumors: the multifaceted role of NFkappaB. Blood 2009; 113:3139-46.
106. Kim YS, Young MR, Bobe G, Colburn NH, Milner JA. Bioactive food components, inflammatory targets and cancer prevention. Cancer Prev Res (Phila Pa) 2009; 2:200-8.
107. Mauro C, Zazzeroni F, Papa S, Bubici C, Franzoso G. The NFkappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NFkappaB activity. Methods Mol Biol 2009; 512:169-207.
108. Zhu F, Park E, Liu B, Xia X, Fischer SM, Hu Y. Critical role of IkappaB kinase alpha in embryonic skin development and skin carcinogenesis. Histol Histopathol 2009; 24:265-71.
109. Kiessling MK, Klemke CD, Kaminski MM, Galani IE, Krammer PH, Gulow K. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res 2009; 69:2365-74.
110. Park SA, Na HK, Kim EH, Cha YN, Surh YJ. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res 2009; 69:2416-24.
111. Ruiz-Ramos R, Lopez-Carrillo L, Rios-Perez AD, De Vizcaya-Ruiz A, Cebrian ME. Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NFkappaB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res 2009; 674:109-15.
112. 2: relevance in inflammation and synergy with TNFalpha. J Immunol 2007; 178:3893-902.
113. Lupertz R, Chovolou Y, Kampkotter A, Watjen W, Kahl R. Catalase overexpression impairs TNFalpha induced NFkappaB activation and sensitizes MCF-7 cells against TNFalpha. J Cell Biochem 2008; 103:1497-511.
114. Cristofanon S, Morceau F, Scovassi AI, Dicato M, Ghibelli L, Diederich M. Oxidative, multistep activation of the noncanonical NFkappaB pathway via disulfide Bcl-3/p50 complex. Faseb J 2009; 23:45-57.
115. Jimenez-Lopez JM, Wu D, Cederbaum AI. Synergistic toxicity induced by prolonged glutathione depletion and inhibition of nuclear factor-kappaB signaling in liver cells. Toxicol In Vitro 2008; 22:106-15.
116. Sarkar FH, Li Y, Wang Z, Kong D. NFkappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 2008; 27:293-319.
117. Janssen-Heininger YM, Poynter ME, Aesif SW, Pantano C, Ather JL, Reynaert NL, et al. Nuclear factor kappaB, airway epithelium and asthma: avenues for redox control. Proc Am Thorac Soc 2009; 6:249-55.
118. Epperly MW, Bernarding M, Gretton J, Jefferson M, Nie S, Greenberger JS. Overexpression of the transgene for manganese superoxide dismutase (MnSOD) in 32D cl 3 cells prevents apoptosis induction by TNFalpha, IL-3 withdrawal, and ionizing radiation. Exp Hematol 2003; 31:465-74.
119. Place RF, Haspeslagh D, Giardina C. Induced stabilization of IkappaBalpha can facilitate its re-synthesis and prevent sequential degradation. J Cell Physiol 2003; 195:470-8.
120. Masamune A, Shimosegawa T. Signal transduction in pancreatic stellate cells. J Gastroenterol 2009; 44:249-60.
121. Palozza P, Serini S, Torsello A, Di Nicuolo F, Piccioni E, Ubaldi V, et al. Beta-carotene regulates NFkappaB DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J Nutr 2003; 133:381-8.
122. Sriram N, Kalayarasan S, Ashokkumar P, Sureshkumar A, Sudhandiran G. Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NFkappaB and ERK-2. Mol Cell Biochem 2008; 311:157-65.
123. Junttila MR, Li SP, Westermarck J. Phosphatasemediated crosstalk between MAPK signaling pathways in the regulation of cell survival. Faseb J 2008; 22:954-65.
124. Mebratu Y, Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 2009; 8:1168-75.
125. McCubrey JA, Steelman LS, Abrams SL, Bertrand FE, Ludwig DE, Basecke J, et al. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia 2008; 22:708-22.
126. Russo AE, Torrisi E, Bevelacqua Y, Perrotta R, Libra M, McCubrey JA, et al. Melanoma: molecular pathogenesis and emerging target therapies (Review). Int J Oncol 2009; 34:1481-9.
127. Eguchi M, Monden K, Miwa N. Role of MAPK phosphorylation in cytoprotection by pro-vitamin C against oxidative stress-induced injuries in cultured cardiomyoblasts and perfused rat heart. J Cell Biochem 2003; 90:219-26.
128. Schraml E, Fuchs R, Kotzbeck P, Grillari J, Schauenstein K. Acute adrenergic stress inhibits proliferation of murine hematopoietic progenitor cells via p38/MAPK signaling. Stem Cells Dev 2009; 18:215-27.
129. Liu B, Yu HM, Huang J, Hsu W. Co-opted JNK/SAPK signaling in Wnt/beta-catenin-induced tumorigenesis. Neoplasia 2008; 10:1004-13.
130. Nguyen HT, Hsieh MH, Gaborro A, Tinloy B, Phillips C, Adam RM. JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and -9 in NRK-52E renal epithelial cells. Nephron Exp Nephrol 2006; 102:22.
131. Matsuzawa A, Ichijo H. Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta 2008; 1780:1325-36.
132. Nadeau PJ, Charette SJ, Toledano MB, Landry J. Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2) O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. Mol Biol Cell 2007; 18:3903-13.
133. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 2003; 8:369-91.
134. Nguyen A, Chang AC, Reddel RR. Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Oncogene 2009; 28:1982-92.
135. Kang GY, Lee ER, Kim JH, Jung JW, Lim J, Kim SK, et al. Downregulation of PLK-1 expression in kaempferol-induced apoptosis of MCF-7 cells. Eur J Pharmacol 2009; 611:17-21.
136. Kim BW, Lee ER, Min HM, Jeong HS, Ahn JY, Kim JH, et al. Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition. Cancer Biol Ther 2008; 7:1080-9.
137. Shim HY, Park JH, Paik HD, Nah SY, Kim DS, Han YS. Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c- Jun activation. Mol Cells 2007; 24:95-104.
138. Kuo PL, Chen CY, Tzeng TF, Lin CC, Hsu YL. Involvement of reactive oxygen species/c-Jun NH(2)- terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells. Toxicol Appl Pharmacol 2008; 229:215-26.
139. Donadelli M, Dalla Pozza E, Costanzo C, Scupoli MT, Piacentini P, Scarpa A, et al. Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate. Biochim Biophys Acta 2006; 1763:917-26.
140. Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, et al. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol 2007; 81:719-28.
141. Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 2006; 25:5640-7.
142. Joo SS, Yoo YM. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res 2009; 47:8-14.
143. Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, et al. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormonerefractory prostate cancer in a preclinical mouse model. J Clin Invest 2008; 118:3051-64.
144. Sanchez AM, Malagarie-Cazenave S, Olea N, Vara D, Chiloeches A, Diaz-Laviada I. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase and JNK activation. Apoptosis 2007; 12:2013-24.
145. Valentini A, Conforti F, Crispini A, De Martino A, Condello R, Stellitano C, et al. Synthesis, oxidant properties and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells. J Med Chem 2009; 52:484-91.
146. Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Guillevin L, et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxelinduced cancer cell death both in vitro and in vivo. Int J Cancer 2006; 119:41-8.
147. Llobet D, Eritja N, Encinas M, Sorolla A, Yeramian A, Schoenenberger JA, et al. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells. Anticancer Drugs 2008; 19:115-24.
148. Guzman ML, Li X, Corbett CA, Rossi RM, Bushnell T, Liesveld JL, et al. Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1, 2, 4-thiadiazolidine, 3, 5 dione (TDZD-8). Blood 2007; 110:4436-44.